DAVID BROWNING: Open Payments
NPI 1073948683 · SOUTH OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 35 payments from 12 companies in 2025. Trend: 2023 $683 · 2024 $604 · 2025 $668
Food & beverage: $583Education: $85
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 8 | $178 |
| Janssen Biotech, Inc. | 6 | $155 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| ABBVIE INC. | 3 | $57 |
| Organon LLC | 5 | $39 |
| Almirall LLC | 1 | $25 |
| Biofrontera Inc. | 1 | $24 |
| GENZYME CORPORATION | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
Products named: TREMFYA, ADBRY, COSENTYX, SKYRIZI, Rhapsido, ANZUPGO, Seysara, AMELUZ.
Industry payments across UT — which companies pay providers there.
